Deal Terms

Biotech deal-term benchmarks from 600+ real licensing transactions

Webfreemiumglobal

Deal Terms benchmarks biotech licensing deal terms, like upfront payments and royalty rates, against more than 600 real transactions sourced from SEC filings, calibrated to a specific asset's phase and indication in seconds. It is aimed at biotech founders and BD executives who negotiate deals without visibility into comparable transactions, replacing costly consulting reports.

Website

Full match profile

Behind the summary, Matchbox keeps a richer profile of Deal Terms - the signals our matcher actually reads to decide when to surface it. It stays private; claim the listing to see and control it.

Problem & pain-point mapping
Who we surface it to (audience fit)
What it's a strong alternative to
Trust & credibility signals

Claim Deal Terms to unlock →

Try Matchbox with your own problem

Describe what is not working - we’ll show you whether Deal Terms (or something else) actually fits.

Try a problem